Clinical Trials

NCT07458347 | RECRUITING | PHASE1
145 participants

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-29
Start Date:
2026-04-21
Completion:
2027-06-30
Conditions
  • KRAS-mutant Non-small Cell Lung Cancer (NSCLC)
  • KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC)
  • KRAS-mutant Colorectal Cancer (CRC)
  • Other KRAS-mutant Solid Tumors
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page